The European Commission has granted Novartis a new indication for Lucentis (ranibizumab) to treat patients with visual i…
Macular Edema
Novartis Receives Positive Opinion on New Diabetic Macular Edema Drug
Novartis has announced that it has received a positive opinion from the Committee for Medicinal Products for Human Use (…
Novartis’ Ranibizumab More Effective Than Laser Treatment in Treating Vision Loss due to Diabetic Macular Edema
Novartis announced that first results of the RESTORE Phase III study show that ranibizumab is significantly more effecti…
JDRF Funded Researchers Test Topical Drug to Treat Diabetic Macular Edema
The Juvenile Diabetes Research Foundation (JDRF) announced that researchers at the Wilmer Eye Institute of Johns Hopkins…
First Treatment For Diabetic Related Eye Disease May Soon Be Available
According to a JDRF press release great progress has been made towards finding a treatment for diabetes-related eye dise…
